Analyst Ratings for Tyra Biosciences
Portfolio Pulse from Benzinga Insights
Tyra Biosciences (NASDAQ:TYRA) has received positive analyst ratings in the last quarter, with 4 bullish ratings and no bearish ones. The average 12-month price target for the company has increased by 33.82% from $17.00 to $22.75.

August 11, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tyra Biosciences has received positive analyst ratings, which could boost investor confidence and potentially drive the stock price up.
Analyst ratings often influence investor sentiment. The positive ratings for Tyra Biosciences indicate that analysts are optimistic about the company's performance, which could encourage more investors to buy the stock, potentially driving the price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100